I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| smooth muscle cell | 21 studies | 39% ± 23% | |
| astrocyte | 13 studies | 35% ± 12% | |
| oligodendrocyte precursor cell | 13 studies | 36% ± 19% | |
| epithelial cell | 8 studies | 25% ± 13% | |
| ciliated cell | 6 studies | 21% ± 3% | |
| pericyte | 6 studies | 50% ± 14% | |
| goblet cell | 5 studies | 29% ± 15% | |
| myofibroblast cell | 5 studies | 54% ± 25% | |
| dendritic cell | 5 studies | 43% ± 13% | |
| cardiac muscle cell | 5 studies | 36% ± 9% | |
| fibroblast | 5 studies | 41% ± 22% | |
| GABAergic neuron | 4 studies | 28% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 21% ± 5% | |
| intestinal crypt stem cell | 4 studies | 39% ± 12% | |
| neuron | 4 studies | 51% ± 23% | |
| connective tissue cell | 4 studies | 51% ± 30% | |
| deuterosomal cell | 3 studies | 22% ± 1% | |
| macrophage | 3 studies | 26% ± 10% | |
| enterocyte | 3 studies | 24% ± 6% | |
| enteroendocrine cell | 3 studies | 30% ± 11% | |
| mesothelial cell | 3 studies | 21% ± 4% | |
| progenitor cell | 3 studies | 51% ± 17% | |
| transit amplifying cell | 3 studies | 23% ± 5% | |
| luminal cell of prostate epithelium | 3 studies | 25% ± 4% | |
| glutamatergic neuron | 3 studies | 30% ± 7% |
